Literature DB >> 3873891

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy.

B R Reed, J C Huff, S K Jones, P W Orton, L A Lee, D A Norris.   

Abstract

Photosensitive eruptions with clinical and histologic features of subacute cutaneous lupus erythematosus and antibodies to SS-A(Ro) antigen occurred in five patients taking hydrochlorothiazide. After drug therapy was discontinued, the eruptions cleared. In one patient anti-SS-A antibodies disappeared after discontinuation of thiazide, and in another rechallenge with hydrochlorothiazide produced an acute dermatitis with a photodistribution. These eruptions may represent a new type of photosensitive drug reaction in which the photoactive drug may be synergistic with anti-SS-A antibody in producing cutaneous lesions of photosensitive subacute cutaneous lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873891     DOI: 10.7326/0003-4819-103-1-49

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Thalidomide-induced orofacial neuropathy.

Authors:  Cynthia O Anyanwu; Campbell L Stewart; Victoria P Werth
Journal:  J Clin Rheumatol       Date:  2014-10       Impact factor: 3.517

2.  Rare Occurrence of Drug Induced Subacute Cutaneous Lupus Erythematosus with Leflunomide Therapy.

Authors:  Harpreet Singh; Gagandeep Sukhija; Vikram Tanwar; Sameer Arora; Jaikrit Bhutani
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  James Neil Gilliam, MD-the career arc of a patient-oriented translational clinical investigation changemaker in rheumatologic skin disease.

Authors:  Richard D Sontheimer
Journal:  Ann Transl Med       Date:  2018-06

4.  Drug-induced subacute cutaneous lupus erythematosus associated with nab-paclitaxel therapy.

Authors:  N W D Lamond; T Younis; K Purdy; M S Dorreen
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

Review 5.  Drug-induced lupus erythematosus: an update on drugs and mechanisms.

Authors:  Ye He; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-09       Impact factor: 5.006

Review 6.  Drug-induced rheumatic syndromes. Diagnosis, clinical features and management.

Authors:  M G Cohen; M V Prowse
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

7.  [Secukinumab-induced subacute-cutaneous lupus erythematosus].

Authors:  C Wehrmann; W Sondermann; A Körber
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 8.  Lupus erythematosus revisited.

Authors:  Annegret Kuhn; Joerg Wenzel; Marc Bijl
Journal:  Semin Immunopathol       Date:  2015-12-04       Impact factor: 11.759

9.  Subacute cutaneous lupus erythematosus following abemaciclib therapy for metastatic breast cancer.

Authors:  David J Kurtyka; Aurash David Mohebbi; Katherine T Burke; Michael A Cardis
Journal:  JAAD Case Rep       Date:  2021-06-03

10.  A pilot study evaluating biomarker development for drug-induced chronic eczematous eruptions of aging individuals.

Authors:  Erika Mae Summers; Nicholas Ray Blickenstaff; Garrett Curtis Coman; Thomas Bernd Martins; Harry Raymond Hill; Richard Dennis Sontheimer
Journal:  Ann Transl Med       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.